Biodexa Pharmaceuticals Plc (BDRX)
1.48
+0.17
(+12.98%)
USD |
NASDAQ |
Apr 30, 16:00
1.42
-0.06
(-4.05%)
After-Hours: 20:00
Biodexa Pharmaceuticals Market Cap: 6.490M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 5.744M |
| April 26, 2024 | 5.700M |
| April 25, 2024 | 3.178M |
| April 24, 2024 | 3.288M |
| April 23, 2024 | 3.544M |
| April 22, 2024 | 3.354M |
| April 19, 2024 | 3.298M |
| April 18, 2024 | 3.596M |
| April 17, 2024 | 3.729M |
| April 16, 2024 | 3.773M |
| April 15, 2024 | 3.613M |
| April 12, 2024 | 4.022M |
| April 11, 2024 | 4.217M |
| April 10, 2024 | 4.255M |
| April 09, 2024 | 4.341M |
| April 08, 2024 | 4.516M |
| April 05, 2024 | 4.692M |
| April 04, 2024 | 5.087M |
| April 03, 2024 | 4.824M |
| April 02, 2024 | 5.964M |
| April 01, 2024 | 6.402M |
| March 28, 2024 | 6.884M |
| March 27, 2024 | 3.650M |
| March 26, 2024 | 3.405M |
| March 25, 2024 | 4.164M |
| Date | Value |
|---|---|
| March 22, 2024 | 4.462M |
| March 21, 2024 | 4.502M |
| March 20, 2024 | 4.462M |
| March 19, 2024 | 4.377M |
| March 18, 2024 | 4.844M |
| March 15, 2024 | 4.972M |
| March 14, 2024 | 4.802M |
| March 13, 2024 | 5.397M |
| March 12, 2024 | 5.397M |
| March 11, 2024 | 5.567M |
| March 08, 2024 | 5.524M |
| March 07, 2024 | 5.567M |
| March 06, 2024 | 5.482M |
| March 05, 2024 | 5.439M |
| March 04, 2024 | 5.524M |
| March 01, 2024 | 5.779M |
| February 29, 2024 | 3.777M |
| February 28, 2024 | 3.926M |
| February 27, 2024 | 4.104M |
| February 26, 2024 | 4.134M |
| February 23, 2024 | 4.431M |
| February 22, 2024 | 4.580M |
| February 21, 2024 | 4.550M |
| February 20, 2024 | 4.818M |
| February 16, 2024 | 4.610M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.677M
Minimum
Mar 31 2023
48.03M
Maximum
Feb 04 2021
16.60M
Average
15.05M
Median
Aug 03 2020
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 293.72M |
| NuCana PLC | 8.310M |
| Autolus Therapeutics PLC | 979.94M |
| Mereo BioPharma Group PLC | 428.53M |
| Bicycle Therapeutics PLC | 889.05M |
Market Cap Related Metrics
| PS Ratio | 4.642 |
| Price to Book Value | 1.089 |
| Price | 1.48 |
| Earnings Yield | -27.16K% |